Global Erythropoietin Stimulating Agents Market 2024-2028

Erythropoietin Stimulating Agents Market 2024-2028


The erythropoietin stimulating agents market is forecasted to grow by USD 4505.4 mn during 2023-2028, accelerating at a CAGR of 8.5% during the forecast period. The report on the erythropoietin stimulating agents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by presence of large pool of ckd patients, rising applications in hiv infections and end-stage renal disorder, and risks of thrombosis, during surgeries, and pure red cell aplasia.

Technavio's erythropoietin stimulating agents market is segmented as below:
  • By Type
  • Epoetin alfa
  • Epoetin beta
  • Darbepoetin alfa
  • Others
  • By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing number of ckd dialysis centers in developing economies as one of the prime reasons driving the erythropoietin stimulating agents market growth during the next few years. Also, increasing instances of strategic collaborations among vendors and increasing investments in research and development for developing new and improved erythropoietin products will lead to sizable demand in the market.

The report on the erythropoietin stimulating agents market covers the following areas:
  • Erythropoietin Stimulating Agents Market sizing
  • Erythropoietin Stimulating Agents Market forecast
  • Erythropoietin Stimulating Agents Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading erythropoietin stimulating agents market vendors that include 3SBio Inc., Akebia Therapeutics, Amgen Inc., Biocon Ltd., Biosidus SA, Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Johnson and Johnson Services Inc., Nanogen Pharmaceutical Biotechnology, NephroPlus, Novartis AG, Pfizer Inc., Reliance Industries Ltd., Renal Project, Thermo Fisher Scientific Inc., and Zydus Lifesciences Ltd.. Also, the erythropoietin stimulating agents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.


1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Erythropoietin Stimulating Agents Market 2018 - 2022
Historic Market Size - Data Table on Global Erythropoietin Stimulating Agents Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
6.3 Epoetin alfa - Market size and forecast 2023-2028
Chart on Epoetin alfa - Market size and forecast 2023-2028 ($ million)
Data Table on Epoetin alfa - Market size and forecast 2023-2028 ($ million)
Chart on Epoetin alfa - Year-over-year growth 2023-2028 (%)
Data Table on Epoetin alfa - Year-over-year growth 2023-2028 (%)
6.4 Epoetin beta - Market size and forecast 2023-2028
Chart on Epoetin beta - Market size and forecast 2023-2028 ($ million)
Data Table on Epoetin beta - Market size and forecast 2023-2028 ($ million)
Chart on Epoetin beta - Year-over-year growth 2023-2028 (%)
Data Table on Epoetin beta - Year-over-year growth 2023-2028 (%)
6.5 Darbepoetin alfa - Market size and forecast 2023-2028
Chart on Darbepoetin alfa - Market size and forecast 2023-2028 ($ million)
Data Table on Darbepoetin alfa - Market size and forecast 2023-2028 ($ million)
Chart on Darbepoetin alfa - Year-over-year growth 2023-2028 (%)
Data Table on Darbepoetin alfa - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 Akebia Therapeutics
Akebia Therapeutics - Overview
Akebia Therapeutics - Product / Service
Akebia Therapeutics - Key offerings
11.4 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
11.5 Biocon Ltd.
Biocon Ltd. - Overview
Biocon Ltd. - Business segments
Biocon Ltd. - Key offerings
Biocon Ltd. - Segment focus
11.6 Biosidus SA
Biosidus SA - Overview
Biosidus SA - Product / Service
Biosidus SA - Key offerings
11.7 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
11.8 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
11.9 Nanogen Pharmaceutical Biotechnology
Nanogen Pharmaceutical Biotechnology - Overview
Nanogen Pharmaceutical Biotechnology - Product / Service
Nanogen Pharmaceutical Biotechnology - Key offerings
11.10 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
11.11 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
11.12 Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Parent Market
Exhibits10: Data Table on - Parent Market
Exhibits11: Market characteristics analysis
Exhibits12: Value Chain Analysis
Exhibits13: Offerings of companies included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Historic Market Size - Data Table on Global Erythropoietin Stimulating Agents Market 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Epoetin alfa - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Epoetin alfa - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Epoetin alfa - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Epoetin alfa - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Epoetin beta - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Epoetin beta - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Epoetin beta - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Epoetin beta - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Darbepoetin alfa - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Darbepoetin alfa - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Darbepoetin alfa - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Darbepoetin alfa - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits50: Market opportunity by Type ($ million)
Exhibits51: Data Table on Market opportunity by Type ($ million)
Exhibits52: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits53: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits54: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits55: Chart on Geographic comparison
Exhibits56: Data Table on Geographic comparison
Exhibits57: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits58: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits59: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits60: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits61: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits62: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits63: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits93: Market opportunity By Geographical Landscape ($ million)
Exhibits94: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits95: Impact of drivers and challenges in 2023 and 2028
Exhibits96: Overview on criticality of inputs and factors of differentiation
Exhibits97: Overview on factors of disruption
Exhibits98: Impact of key risks on business
Exhibits99: Companies covered
Exhibits100: Matrix on companies position and classification
Exhibits101: Akebia Therapeutics - Overview
Exhibits102: Akebia Therapeutics - Product / Service
Exhibits103: Akebia Therapeutics - Key offerings
Exhibits104: Amgen Inc. - Overview
Exhibits105: Amgen Inc. - Product / Service
Exhibits106: Amgen Inc. - Key news
Exhibits107: Amgen Inc. - Key offerings
Exhibits108: Biocon Ltd. - Overview
Exhibits109: Biocon Ltd. - Business segments
Exhibits110: Biocon Ltd. - Key offerings
Exhibits111: Biocon Ltd. - Segment focus
Exhibits112: Biosidus SA - Overview
Exhibits113: Biosidus SA - Product / Service
Exhibits114: Biosidus SA - Key offerings
Exhibits115: F. Hoffmann La Roche Ltd. - Overview
Exhibits116: F. Hoffmann La Roche Ltd. - Business segments
Exhibits117: F. Hoffmann La Roche Ltd. - Key news
Exhibits118: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits119: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits120: Johnson and Johnson Services Inc. - Overview
Exhibits121: Johnson and Johnson Services Inc. - Business segments
Exhibits122: Johnson and Johnson Services Inc. - Key news
Exhibits123: Johnson and Johnson Services Inc. - Key offerings
Exhibits124: Johnson and Johnson Services Inc. - Segment focus
Exhibits125: Nanogen Pharmaceutical Biotechnology - Overview
Exhibits126: Nanogen Pharmaceutical Biotechnology - Product / Service
Exhibits127: Nanogen Pharmaceutical Biotechnology - Key offerings
Exhibits128: Novartis AG - Overview
Exhibits129: Novartis AG - Business segments
Exhibits130: Novartis AG - Key news
Exhibits131: Novartis AG - Key offerings
Exhibits132: Novartis AG - Segment focus
Exhibits133: Pfizer Inc. - Overview
Exhibits134: Pfizer Inc. - Product / Service
Exhibits135: Pfizer Inc. - Key news
Exhibits136: Pfizer Inc. - Key offerings
Exhibits137: Thermo Fisher Scientific Inc. - Overview
Exhibits138: Thermo Fisher Scientific Inc. - Business segments
Exhibits139: Thermo Fisher Scientific Inc. - Key news
Exhibits140: Thermo Fisher Scientific Inc. - Key offerings
Exhibits141: Thermo Fisher Scientific Inc. - Segment focus
Exhibits142: Inclusions checklist
Exhibits143: Exclusions checklist
Exhibits144: Currency conversion rates for US$
Exhibits145: Research methodology
Exhibits146: Information sources
Exhibits147: Data validation
Exhibits148: Validation techniques employed for market sizing
Exhibits149: Data synthesis
Exhibits150: 360 degree market analysis
Exhibits151: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings